These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34911883)

  • 1. Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease.
    Soga Y; Takahara M; Iida O; Suzuki K; Mori S; Kawasaki D; Haraguchi K; Yamaoka T; Ando K
    J Atheroscler Thromb; 2022 Oct; 29(10):1448-1457. PubMed ID: 34911883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis.
    Iida O; Soga Y; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M; Muramatsu T; Inoue N; Nanto S; Uematsu M
    J Endovasc Ther; 2011 Dec; 18(6):753-61. PubMed ID: 22149222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity Score Analysis Comparing Clinical Outcomes of Drug-Eluting vs Bare Nitinol Stents in Femoropopliteal Lesions.
    Soga Y; Takahara M; Iida O; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Ando K
    J Endovasc Ther; 2016 Feb; 23(1):33-9. PubMed ID: 26763256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Primary Patency and Lesion Length Following Bare Nitinol Stent Placement for Femoropopliteal Disease.
    Soga Y; Takahara M; Iida O; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Yamaoka T; Ando K
    J Endovasc Ther; 2015 Dec; 22(6):862-7. PubMed ID: 26438352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Stent Thrombosis Leading to Acute Limb Ischemia and Major Amputation: Incidence and Risk Factors in the Aortoiliac and Femoropopliteal Arteries.
    Katsanos K; Al-Lamki SA; Parthipun A; Spiliopoulos S; Patel SD; Paraskevopoulos I; Zayed H; Diamantopoulos A
    Cardiovasc Intervent Radiol; 2017 Mar; 40(3):351-359. PubMed ID: 27921154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
    Armstrong EJ; Jeon-Slaughter H; Kahlon RS; Niazi KA; Shammas NW; Banerjee S
    J Endovasc Ther; 2020 Feb; 27(1):60-65. PubMed ID: 31686573
    [No Abstract]   [Full Text] [Related]  

  • 9. One-Year Clinical Outcomes following Implantation of Innova
    Tsujimura T; Takahara M; Iida O; Hiramori S; Hayakawa N; Karashima E; Miura T; Teramura M; Ichihashi K; Kojima T; Aihara H; Yamaoka T; Fujihara M; Tosaka A; Doijiri T; Mano T; Soga Y
    J Atheroscler Thromb; 2019 Oct; 26(10):847-855. PubMed ID: 30842350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Multicenter Comparison Between Viabahn Covered Stent-Grafts and Supera Interwoven Nitinol Stents for Endovascular Treatment in Severely Calcified Femoropopliteal Artery Disease: The ARMADILLO Study (Adjusted Retrospective coMparison of scAffolDs In caLcified LesiOns).
    Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
    J Endovasc Ther; 2024 Jun; 31(3):400-409. PubMed ID: 36146948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year outcomes of self-expanding nitinol stent implantation for chronic total occlusion of the superficial femoral and proximal popliteal artery.
    Sakamoto Y; Hirano K; Iida O; Soga Y; Suzuki K; Muramatsu T; Tsukahara R
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E251-6. PubMed ID: 23536429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Year Clinical Outcomes Following Implantation of LifeStent Self-Expanding Nitinol Stents in Patients With Femoropopliteal Artery Lesions.
    Tan M; Takahara M; Soga Y; Mori S; Tsuchiya T; Mazaki T; Shintani Y; Noguchi M; Taniguchi M; Kobayashi Y; Nakazato J; Urasawa K
    Angiology; 2022 Mar; 73(3):244-251. PubMed ID: 34493086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-coated stent implantation vs. bypass surgery for in-stent occlusion after femoropopliteal stenting.
    Tomoi Y; Soga Y; Okazaki J; Iida O; Shiraki T; Hiramori S; Ando K
    Heart Vessels; 2021 May; 36(5):646-653. PubMed ID: 33392645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitinol stent implantation for femoropopliteal disease in patients on hemodialysis: results of the 3-year retrospective multicenter APOLLON study.
    Fujihara M; Higashimori A; Kato Y; Taniguchi H; Iwasaki Y; Amano T; Sumiyoshi A; Nishiya D; Yokoi Y
    Heart Vessels; 2016 Sep; 31(9):1476-83. PubMed ID: 26337619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Statin Therapy on Restenosis in Patients Who Underwent Nitinol Stent Implantation for de Novo Femoropopliteal Artery Disease: Two-Year Follow-up at a Single Center.
    Kim W; Gandhi RT; Peña CS; Herrera RE; Schernthaner MB; Acuña JM; Becerra VN; Katzen BT
    J Vasc Interv Radiol; 2016 Oct; 27(10):1494-501. PubMed ID: 27522274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
    Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
    J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.